Proceedings of the 2016 China Cancer Immunotherapy Workshop

by Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu, Zihai Li, Zihai Li, Lieping Chen, Edward B. Garon, Siwen Hu-Lieskovan, Wei Ding, Chong-Xian Pan, Weijing Sun, Yong-Jun Liu, Lei Zheng, Delong Liu, Michel Sadelain, Cassian Yee, Rongfu Wang, Meixia Chen, Yao Wang, Zhiqiang Wu, Hanren Dai, Can Luo, Yang Liu, Chuan Tong, Yelei Guo, Qingming Yang, Weidong Han, Lisa H. Butterfield, Timothy A. Chan, Wenru Song, Ruirong Yuan, Bo Lu, Ke Liu, Max Ning, Harald Enzmann, Heinz Zwierzina
Published 2016-10-01

A review on the advances and challenges of immunotherapy for head and neck cancer

by Gang Cheng, Hui Dong, Chen Yang, Yang Liu, Yi Wu, Lifen Zhu, Xiangmin Tong, Shibing Wang
Published 2021-07-01

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

by Yajing Zhang, Jin Wang, Yao Wang, Xue-Chun Lu, Hui Fan, Yang Liu, Yan Zhang, Kai-Chao Feng, Wen-Ying Zhang, Mei-Xia Chen, Xiaobing Fu, Wei-Dong Han
Published 2013-01-01

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?

by Fei Tang, Xuexiang Du, Mingyue Liu, Pan Zheng, Yang Liu
Published 2018-04-01

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer

by Jun Ni, Miao Huang, Li Zhang, Nan Wu, Chun‐Xue Bai, Liang‐An Chen, Jun Liang, Qian Liu, Jie Wang, Yi‐Long Wu, Feng‐Chun Zhang, Shu‐Yang Zhang, Chun Chen, Jun Chen, Wen‐Tao Fang, Shu‐Geng Gao, Jian Hu, Tao Jiang, Shan‐Qing Li, He‐Cheng Li, Yong‐De Liao, Yang Liu, De‐Ruo Liu, Hong‐Xu Liu, Jian‐Yang Liu, Lun‐Xu Liu, Meng‐Zhao Wang, Chang‐Li Wang, Fan Yang, Yue Yang, Lan‐Jun Zhang, Xiu‐Yi Zhi, Wen‐Zhao Zhong, Yu‐Zhou Guan, Xiao‐Xiao Guo, Chun‐Xia He, Shao‐Lei Li, Yue Li, Nai‐Xin Liang, Fang‐Liang Lu, Chao Lv, Wei Lv, Xiao‐Yan Si, Feng‐Wei Tan, Han‐Ping Wang, Jiang‐Shan Wang, Shi Yan, Hua‐Xia Yang, Hui‐Juan Zhu, Jun‐Ling Zhuang, Ming‐Lei Zhuo
Published 2021-05-01

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

by Yang Liu, Yinping Dong, Li Kong, Fang Shi, Hui Zhu, Jinming Yu
Published 2018-08-01

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

by Kai-chao Feng, Ye-lei Guo, Yang Liu, Han-ren Dai, Yao Wang, Hai-yan Lv, Jian-hua Huang, Qing-ming Yang, Wei-dong Han
Published 2017-01-01

Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells

by Feng Li, Bingke Lv, Yang Liu, Tian Hua, Jianbang Han, Chengmei Sun, Limin Xu, Zhongfei Zhang, Zhiming Feng, Yingqian Cai, Yuxi Zou, Yiquan Ke, Xiaodan Jiang
Published 2018-02-01

Integrated Analysis of Immune Infiltration Features for Cervical Carcinoma and Their Associated Immunotherapeutic Responses

by Yanan Kang, Jin Huang, Jin Huang, Yang Liu, Nan Zhang, Quan Cheng, Quan Cheng, Quan Cheng, Yi Zhang
Published 2021-04-01

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

by Hanren Dai, Zhiqiang Wu, Hejin Jia, Chuan Tong, Yelei Guo, Dongdong Ti, Xiao Han, Yang Liu, Wenying Zhang, Chunmeng Wang, Yajing Zhang, Meixia Chen, Qingming Yang, Yao Wang, Weidong Han
Published 2020-04-01

Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer

by Xin Yan, Xin Yan, Yongtian Zhao, Yang Liu, Qingming Yang, Liang Dong, Zhiqiang Wu, Jing Nie, Deyun Chen, Miaomiao Bai, Dongdong Ti, Kaichao Feng, Weidong Han, Weidong Han
Published 2020-10-01

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis

by Rui Cao, Jie‐Tao Ma, Shu‐Ling Zhang, Li Sun, Yang Liu, Xiang‐Yan Zhang, Wei Jing, Le‐Tian Huang, Cheng‐Bo Han
Published 2019-09-01

Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies

by Peng Zhang, Xinxin Xiong, Christian Rolfo, Xuexiang Du, Yan Zhang, Han Yang, Alessandro Russo, Martin Devenport, Penghui Zhou, Yang Liu, Pan Zheng
Published 2020-01-01

Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma

by Xiaohu Huang, Yan Liu, Yin Wang, Christopher Bailey, Pan Zheng, Yang Liu
Published 2021-02-01

The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

by Gong Peng, Yin Wang, Pengfei Ge, Christopher Bailey, Peng Zhang, Di Zhang, Zhaoli Meng, Chong Qi, Qian Chen, Jingtao Chen, Junqi Niu, Pan Zheng, Yang Liu, Yan Liu
Published 2021-09-01

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer

by Peng Zhang, Pan Zheng, Pan Zheng, Yang Liu, Yang Liu
Published 2019-06-01

The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer

by Yan Zhang, Qian Mei, Yang Liu, Xiang Li, Malcolm V. Brock, Meixia Chen, Liang Dong, Lu Shi, Yao Wang, Mingzhou Guo, Jing Nie, Weidong Han
Published 2017-09-01

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature

by Feifei Wang, Yang Liu, Wei Xu, Changjing Zhang, Jianhong Lv, Shaolin Ma
Published 2021-07-01

Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population

by Yalong Qi, Daixiang Liao, Dinglian Mei, Yong Zhang, Yang Liu
Published 2020-09-01

Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade

by Yang Liu, Jing Cai, Wenfeng Liu, Yuan Lin, Li Guo, Xincheng Liu, Zhen Qin, Cuiying Xu, Yanming Zhang, Xingwen Su, Kai Deng, Guangmei Yan, Jiankai Liang
Published 2020-12-01